##gff-version 3
##sequence-region P78329 1 520
P78329	UniProtKB	Propeptide	1	4	.	.	.	ID=PRO_0000430581;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9799565;Dbxref=PMID:9799565	
P78329	UniProtKB	Chain	5	520	.	.	.	ID=PRO_0000051850;Note=Phylloquinone omega-hydroxylase CYP4F2	
P78329	UniProtKB	Metal binding	468	468	.	.	.	Note=Iron (heme axial ligand);Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P24464	
P78329	UniProtKB	Binding site	328	328	.	.	.	Note=Heme (covalent%3B via 1 link);Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P24464	
P78329	UniProtKB	Alternative sequence	1	149	.	.	.	ID=VSP_055578;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P78329	UniProtKB	Alternative sequence	307	339	.	.	.	ID=VSP_055579;Note=In isoform 2. DEDGKKLSDEDIRAEADTFMFEGHDTTASGLSW->AMTPRPVVSPGSCTTLQSTQNTRSAAGRRCKNF;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P78329	UniProtKB	Alternative sequence	340	520	.	.	.	ID=VSP_055580;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P78329	UniProtKB	Natural variant	7	7	.	.	.	ID=VAR_013116;Note=S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs3093104	
P78329	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_013117;Note=W->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:9799565,ECO:0000269|Ref.5;Dbxref=dbSNP:rs3093105,PMID:15489334,PMID:9799565	
P78329	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_013118;Note=G->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|Ref.5;Dbxref=dbSNP:rs3093153,PMID:14702039	
P78329	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_020125;Note=A->D;Dbxref=dbSNP:rs1805040	
P78329	UniProtKB	Natural variant	433	433	.	.	.	ID=VAR_013119;Note=Polymorphism probably associated with CMRES%3B increases warfarin maintenance dose in patients on warfarin anti-coagulant therapy%2C possibly due to increased hepatic vitamin K levels that warfarin must antagonize. Decreased phylloquinone omega-hydroxylase activity. Decreased production of 20-hydroxyeicosatetraenoic acid (20-HETE). V->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:17341693,ECO:0000269|PubMed:18250228,ECO:0000269|PubMed:18574070,ECO:0000269|PubMed:19207028,ECO:0000269|PubMed:19270263,ECO:0000269|PubMed:19297519,ECO:0000269|PubMed:20555338,ECO:0000269|PubMed:23132553,ECO:0000269|Ref.5;Dbxref=dbSNP:rs2108622,PMID:15489334,PMID:17341693,PMID:18250228,PMID:18574070,PMID:19207028,PMID:19270263,PMID:19297519,PMID:20555338,PMID:23132553	
P78329	UniProtKB	Natural variant	519	519	.	.	.	ID=VAR_013120;Note=L->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs3093200	
P78329	UniProtKB	Sequence conflict	12	13	.	.	.	Note=WP->CR;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P78329	UniProtKB	Sequence conflict	12	13	.	.	.	Note=WP->CR;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P78329	UniProtKB	Sequence conflict	25	25	.	.	.	Note=V->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P78329	UniProtKB	Sequence conflict	169	169	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P78329	UniProtKB	Sequence conflict	336	336	.	.	.	Note=G->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P78329	UniProtKB	Sequence conflict	391	391	.	.	.	Note=L->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
